Financials

  • Market Capitalization 585.74 M
  • Employee 200
  • Founded 2015
  • CEO N/A
  • Website www.ars-pharma.com
  • Headquarter Delaware, United States
  • FIGI BBG00FZQGXG3
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.69
Rapporto prezzo/fatturato
6.78

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
2800
ALT
Altimmune, Inc. - Common Stock
3.11 USD-4.01%0.00%+4.01%-18.37%604.95 M USD
2808
ARVN
Arvinas, Inc. - Common Stock
9.18 USD-0.65%-2.13%+11.41%-1.29%600.25 M USD
2831
MPLT
MapLight Therapeutics, Inc. - Common Stock
12.60 USD+0.48%+12.40%-12.62%-33.68%584.36 M USD
2855
VALN
Valneva SE - American Depositary Shares
6.43 USD-2.28%-3.74%+26.33%-20.22%557.93 M USD

Notizie